Accelerative effect of polaprezinc on healing gastric ulcer after eradication of Helicobacter pylori infection

Trial Profile

Accelerative effect of polaprezinc on healing gastric ulcer after eradication of Helicobacter pylori infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2016

At a glance

  • Drugs Polaprezinc (Primary) ; Amoxicillin; Clarithromycin; Lansoprazole
  • Indications Bacterial infections; Gastric ulcer
  • Focus Therapeutic Use
  • Sponsors Zeria
  • Most Recent Events

    • 14 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top